Drop in Prostate Cancer Screening Reveals Split Among Doctors

After U.S. guidelines advised against routine tests, declines in prostate cancer screening have been sharper among primary care doctors than urologists, according to a new study that suggests the medical community remains divided over the best way to look for these tumors.

“There is much evidence that men with limited life expectancy do not benefit from PSA testing, and I think experts can agree on that,” said senior study author Dr. Quoc-Dien Trinh, a urologist at Brigham and Women’s Hospital in Boston.

Source: REUTERS HEALTH NEWS